Recursion Pharmaceuticals, Inc. RXRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease ROU assets of $42.82M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 19.5% year-over-year, from $53.19M to $42.82M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 8.3% compound annual growth rate (CAGR), from $32.9M to $45.34M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.